Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Immuno-checkpoint inhibitors in metastatic esophago-gastric cancer.

Schena M, Battaglia AF, Trogu A.

J Thorac Dis. 2019 Mar;11(Suppl 3):S376-S380. doi: 10.21037/jtd.2018.12.71. No abstract available.

2.

Immunotherapy Associated Pulmonary Toxicity: Biology Behind Clinical and Radiological Features.

Porcu M, De Silva P, Solinas C, Battaglia A, Schena M, Scartozzi M, Bron D, Suri JS, Willard-Gallo K, Sangiolo D, Saba L.

Cancers (Basel). 2019 Mar 5;11(3). pii: E305. doi: 10.3390/cancers11030305. Review.

3.

Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform.

Quiñones B, Lee BG, Martinsky TJ, Yambao JC, Haje PK, Schena M.

Sensors (Basel). 2017 Sep 20;17(9). pii: E2157. doi: 10.3390/s17092157.

4.

Esophageal cancer developed in a radiated field: can we reduce the risk of a poor prognosis cancer?

Schena M, Battaglia AF, Munoz F.

J Thorac Dis. 2017 Jul;9(7):1767-1771. doi: 10.21037/jtd.2017.06.45. No abstract available.

5.

Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients.

Franco P, Rampino M, Ostellino O, Schena M, Pecorari G, Garzino Demo P, Fasolis M, Arcadipane F, Martini S, Cavallin C, Airoldi M, Ricardi U.

Med Oncol. 2017 Feb;34(2):30. doi: 10.1007/s12032-017-0886-5. Epub 2017 Jan 18.

PMID:
28101834
6.

Parameters and outcomes in 525 patients operated on for oral squamous cell carcinoma.

Garzino-Demo P, Zavattero E, Franco P, Fasolis M, Tanteri G, Mettus A, Tosco P, Chiusa L, Airoldi M, Ostellino O, Schena M, Rampino M, Ricardi U, Evangelista A, Merletti F, Berrone S, Ramieri G.

J Craniomaxillofac Surg. 2016 Sep;44(9):1414-21. doi: 10.1016/j.jcms.2016.06.007. Epub 2016 Jun 15.

PMID:
27485718
7.

Induction Chemotherapy and Sequential Concomitant Chemo-radiation in Locally Advanced Head and Neck Cancers: How Induction-phase Intensity and Treatment Breaks May Impact on Clinical Outcomes.

Franco P, Potenza I, Schena M, Riva G, Pecorari G, Garzino Demo P, Fasolis M, Moretto F, Garzaro M, Di Muzio J, Melano M, Airoldi M, Ragona R, Rampino M, Ricardi U.

Anticancer Res. 2015 Nov;35(11):6247-54.

PMID:
26504058
8.

Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatment.

Moretto F, Rampino M, Munoz F, Ruo Redda MG, Reali A, Balcet V, Badellino S, Piva C, Schena M, Airoldi M, Ostellino O, Pecorari G, Ragona R, Ricardi U.

Radiol Med. 2014 Aug;119(8):634-41. doi: 10.1007/s11547-013-0359-7. Epub 2014 Jan 15.

PMID:
24424659
9.

Neoadjuvant chemo-radiotherapy for locally advanced esophageal cancer: a monocentric study.

Schena M, La Rovere E, Solerio D, Bustreo S, Barone C, Daniele L, Buffoni L, Bironzo P, Sapino A, Gasparri G, Ciuffreda L, Ricardi U.

Tumori. 2012 Jul-Aug;98(4):451-7. doi: 10.1700/1146.12639.

PMID:
23052161
10.

FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer.

Novarino AM, Satolli MA, Chiappino I, Giacobino A, Napoletano R, Ceccarelli M, Ciccone G, Schena M, Bertetto O, Ciuffreda L.

Am J Clin Oncol. 2013 Oct;36(5):466-71. doi: 10.1097/COC.0b013e31825691c3.

PMID:
22781390
11.

Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.

Asioli S, Maletta F, Verdun di Cantogno L, Satolli MA, Schena M, Pecchioni C, Botta C, Chiusa L, Molinaro L, Conti L, Viale G, Ingravallo G, Maiorano E, Sapino A.

Hum Pathol. 2012 Nov;43(11):2070-9. doi: 10.1016/j.humpath.2012.02.017. Epub 2012 Jun 1.

12.

DNA repair gene expression level in peripheral blood and tumour tissue from non-small cell lung cancer and head and neck squamous cell cancer patients.

Schena M, Guarrera S, Buffoni L, Salvadori A, Voglino F, Allione A, Pecorari G, Ruffini E, Garzino-Demo P, Bustreo S, Consito L, Bironzo P, Matullo G.

DNA Repair (Amst). 2012 Apr 1;11(4):374-80. doi: 10.1016/j.dnarep.2012.01.003. Epub 2012 Jan 28.

PMID:
22284908
13.

Efficacy and feasibility of induction chemotherapy and radiotherapy plus cetuximab in head and neck cancer.

Rampino M, Bacigalupo A, Russi E, Schena M, Lastrucci L, Iotti C, Reali A, Musu A, Balcet V, Piva C, Bustreo S, Munoz F, Ragona R, Corvò R, Ricardi U.

Anticancer Res. 2012 Jan;32(1):195-9.

PMID:
22213307
14.

Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.

Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, Schena M, Tinivella M, Tiozzo E, Catalano MG, Pugliese M, Fortunati N, Aragno M, Muzio G, Maggiora M, Oraldi M, Canuto RA.

Br J Nutr. 2012 Jul;108(2):327-33. doi: 10.1017/S0007114511005551. Epub 2011 Nov 25.

15.

The effects of Reiki therapy on pain and anxiety in patients attending a day oncology and infusion services unit.

Birocco N, Guillame C, Storto S, Ritorto G, Catino C, Gir N, Balestra L, Tealdi G, Orecchia C, Vito GD, Giaretto L, Donadio M, Bertetto O, Schena M, Ciuffreda L.

Am J Hosp Palliat Care. 2012 Jun;29(4):290-4. doi: 10.1177/1049909111420859. Epub 2011 Oct 13.

PMID:
21998438
16.

Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.

Rampino M, Ricardi U, Munoz F, Reali A, Barone C, Musu AR, Balcet V, Franco P, Grillo R, Bustreo S, Pecorari G, Cavalot A, Garzino Demo P, Ciuffreda L, Ragona R, Schena M.

Clin Oncol (R Coll Radiol). 2011 Mar;23(2):134-40. doi: 10.1016/j.clon.2010.09.004. Epub 2010 Oct 27.

17.

Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumors.

Caponigro F, Lorusso D, Fornari G, Barone C, Merlano M, Airoldi M, Schena M, MacArthur R, Weitman S, Jannuzzo MG, Crippa S, Fiorentini F, Petroccione A, Comis S.

Cancer Chemother Pharmacol. 2010 Jul;66(2):389-94. doi: 10.1007/s00280-009-1175-6. Epub 2009 Nov 22.

PMID:
20480279
18.

Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression.

Rittà M, De Andrea M, Mondini M, Mazibrada J, Giordano C, Pecorari G, Garzaro M, Landolfo V, Schena M, Chiusa L, Landolfo S.

Head Neck. 2009 Mar;31(3):318-27. doi: 10.1002/hed.20977.

19.

[The implementation of NEMS and NAS systems to assess the nursing staffing levels in a polyvalent intensive care unit].

Lucchini A, Chinello V, Lollo V, De Filippis C, Schena M, Elli S, Sasso M, Pelucchi G, Poloniato L, Martino M, Costanzo A, Vimercati S.

Assist Inferm Ric. 2008 Jan-Mar;27(1):18-26. Italian.

PMID:
18757003
20.

Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.

Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M.

Anticancer Res. 2008 Mar-Apr;28(2B):1285-91.

21.

Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?

Dongiovanni D, Daniele L, Barone C, Dongiovanni V, Fissore C, Sapino A, Macrì L, Bussolati G, Buffoni L, Gaspari F, Grillo R, Birocco N, Addeo A, Ciuffreda L, Schena M.

Lung Cancer. 2008 Jul;61(1):73-81. doi: 10.1016/j.lungcan.2007.12.007. Epub 2008 Feb 19.

PMID:
18243402
22.

Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.

Daniele L, Macrì L, Schena M, Dongiovanni D, Bonello L, Armando E, Ciuffreda L, Bertetto O, Bussolati G, Sapino A.

Mol Cancer Ther. 2007 Apr;6(4):1223-9. Epub 2007 Apr 3.

23.

Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.

Buffoni L, Dongiovanni D, Barone C, Fissore C, Ottaviani D, Dongiovanni V, Grillo R, Salvadori A, Birocco N, Schena M, Bertetto O.

Lung Cancer. 2006 Dec;54(3):353-7. Epub 2006 Oct 17.

PMID:
17049672
24.

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.

MAQC Consortium, Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, Luo Y, Sun YA, Willey JC, Setterquist RA, Fischer GM, Tong W, Dragan YP, Dix DJ, Frueh FW, Goodsaid FM, Herman D, Jensen RV, Johnson CD, Lobenhofer EK, Puri RK, Schrf U, Thierry-Mieg J, Wang C, Wilson M, Wolber PK, Zhang L, Amur S, Bao W, Barbacioru CC, Lucas AB, Bertholet V, Boysen C, Bromley B, Brown D, Brunner A, Canales R, Cao XM, Cebula TA, Chen JJ, Cheng J, Chu TM, Chudin E, Corson J, Corton JC, Croner LJ, Davies C, Davison TS, Delenstarr G, Deng X, Dorris D, Eklund AC, Fan XH, Fang H, Fulmer-Smentek S, Fuscoe JC, Gallagher K, Ge W, Guo L, Guo X, Hager J, Haje PK, Han J, Han T, Harbottle HC, Harris SC, Hatchwell E, Hauser CA, Hester S, Hong H, Hurban P, Jackson SA, Ji H, Knight CR, Kuo WP, LeClerc JE, Levy S, Li QZ, Liu C, Liu Y, Lombardi MJ, Ma Y, Magnuson SR, Maqsodi B, McDaniel T, Mei N, Myklebost O, Ning B, Novoradovskaya N, Orr MS, Osborn TW, Papallo A, Patterson TA, Perkins RG, Peters EH, Peterson R, Philips KL, Pine PS, Pusztai L, Qian F, Ren H, Rosen M, Rosenzweig BA, Samaha RR, Schena M, Schroth GP, Shchegrova S, Smith DD, Staedtler F, Su Z, Sun H, Szallasi Z, Tezak Z, Thierry-Mieg D, Thompson KL, Tikhonova I, Turpaz Y, Vallanat B, Van C, Walker SJ, Wang SJ, Wang Y, Wolfinger R, Wong A, Wu J, Xiao C, Xie Q, Xu J, Yang W, Zhang L, Zhong S, Zong Y, Slikker W Jr.

Nat Biotechnol. 2006 Sep;24(9):1151-61.

25.

Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma.

Garzino-Demo P, Dell'Acqua A, Dalmasso P, Fasolis M, La Terra Maggiore GM, Ramieri G, Berrone S, Rampino M, Schena M.

J Craniomaxillofac Surg. 2006 Sep;34(6):344-50. Epub 2006 Jul 21.

PMID:
16859913
26.

Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression.

De Petrini M, Rittà M, Schena M, Chiusa L, Campisi P, Giordano C, Landolfo V, Pecorari G, Landolfo S.

New Microbiol. 2006 Jan;29(1):25-33.

PMID:
16608122
27.

Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.

Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O.

Cancer Chemother Pharmacol. 2005 Mar;55(3):271-6. Epub 2004 Nov 16.

PMID:
15592837
28.

Microarrays as toxin sensors.

Schena M.

Pharmacogenomics J. 2003;3(3):125-7. No abstract available.

PMID:
12815361
29.

Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha.

Atzeni F, Schena M, Ongari AM, Carrabba M, Bonara P, Minonzio F, Capsoni F.

Cell Immunol. 2002 Nov;220(1):20-9.

PMID:
12718936
30.

Trends in microarray analysis.

Stears RL, Martinsky T, Schena M.

Nat Med. 2003 Jan;9(1):140-5. No abstract available.

PMID:
12514728
31.

Expression monitoring using cDNA microarrays. A general protocol.

Lou XJ, Schena M, Horrigan FT, Lawn RM, Davis RW.

Methods Mol Biol. 2001;175:323-40. Review. No abstract available.

PMID:
11462845
32.

In situ hybridization and immunocytochemistry of alpha1-adrenoceptors in human peripheral blood lymphocytes.

Tayebati SK, Bronzetti E, Morra Di Cella S, Mulatero P, Ricci A, Rossodivita I, Schena M, Schiavone D, Veglio F, Amenta F.

J Auton Pharmacol. 2000 Oct-Dec;20(5-6):305-12.

PMID:
11350496
33.

Identification of the SAAT gene involved in strawberry flavor biogenesis by use of DNA microarrays.

Aharoni A, Keizer LC, Bouwmeester HJ, Sun Z, Alvarez-Huerta M, Verhoeven HA, Blaas J, van Houwelingen AM, De Vos RC, van der Voet H, Jansen RC, Guis M, Mol J, Davis RW, Schena M, van Tunen AJ, O'Connell AP.

Plant Cell. 2000 May;12(5):647-62.

34.

Fluorescence-based expression monitoring using microarrays.

Winzeler EA, Schena M, Davis RW.

Methods Enzymol. 1999;306:3-18. Review. No abstract available.

PMID:
10432445
35.

Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics.

Parolari A, Alamanni F, Gherli T, Bertera A, Dainese L, Costa C, Schena M, Sisillo E, Spirito R, Porqueddu M, Rona P, Biglioli P.

Ann Thorac Surg. 1999 May;67(5):1320-7.

PMID:
10355405
36.

Vasoactive hormones induce nitric oxide synthase mRNA expression and nitric oxide production in human endothelial cells and monocytes.

Schena M, Mulatero P, Schiavone D, Mengozzi G, Tesio L, Chiandussi L, Veglio F.

Am J Hypertens. 1999 Apr;12(4 Pt 1):388-97.

PMID:
10232499
37.

[Oxygen consumption during cardiovascular surgery conducted under extra-corporeal circulation].

Alamanni F, Parolari A, Gherli T, Dainese L, Bertera A, Costa C, Schena M, Biglioli P.

Minerva Cardioangiol. 1998 Nov;46(11):445-53. Italian.

PMID:
10207292
38.

Ca2+ channels of the L-type in peripheral blood lymphocytes of essential hypertensives.

Ricci A, Bronzetti E, Ferrante F, Mignini F, Mulatero P, Schena M, Veglio F, Amenta F.

Am J Hypertens. 1999 Jan;12(1 Pt 1):40-6.

PMID:
10075383
39.

alpha1-adrenergic receptor subtypes in human peripheral blood lymphocytes.

Ricci A, Bronzetti E, Conterno A, Greco S, Mulatero P, Schena M, Schiavone D, Tayebati SK, Veglio F, Amenta F.

Hypertension. 1999 Feb;33(2):708-12.

PMID:
10024333
40.

Microarrays: biotechnology's discovery platform for functional genomics.

Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW.

Trends Biotechnol. 1998 Jul;16(7):301-6. Review.

PMID:
9675914
41.

Dopamine D3 receptor in peripheral mononuclear cells of essential hypertensives.

Ricci A, Bronzetti E, Mulatero P, Schena M, Veglio F, Amenta F.

Hypertension. 1997 Dec;30(6):1566-71.

PMID:
9403584
42.

Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2150-5.

43.
44.

Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.

Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW.

Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10614-9.

45.

Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale.

Schena M, Clini E, Errera D, Quadri A.

Chest. 1996 Jun;109(6):1446-51.

PMID:
8769491
46.

Genome analysis with gene expression microarrays.

Schena M.

Bioessays. 1996 May;18(5):427-31. Review.

PMID:
8639166
47.

Dopamine D5 receptor expression is unchanged in peripheral blood lymphocytes in essential hypertension.

Ricci A, Chiandussi L, Schena M, Schiavone D, Veglio F, Amenta F.

Clin Exp Hypertens. 1995 Nov;17(8):1157-72.

PMID:
8563694
48.

Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Schena M, Shalon D, Davis RW, Brown PO.

Science. 1995 Oct 20;270(5235):467-70.

PMID:
7569999
49.

Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens.

Dazzi F, D'Andrea E, Biasi G, De Silvestro G, Gaidano G, Schena M, Tison T, Vianello F, Girolami A, Caligaris-Cappio F.

Clin Immunol Immunopathol. 1995 Apr;75(1):26-32.

PMID:
7882591
50.

Professional figures in intermediate intensive units.

Quadri A, Simoni P, Clini E, Errera D, Foglio K, Vitacca M, Schena M.

Monaldi Arch Chest Dis. 1994 Dec;49(6):544-6.

PMID:
7711713

Supplemental Content

Loading ...
Support Center